Resistance to differentiation therapy

Keyphrases

• All-trans Retinoic Acid 100%
• Differentiation Therapy 100%
• Acute Promyelocytic Leukemia 40%
• Acid Activation 20%
• Molecular Mechanism 10%
• Phorbol Ester 10%
• Interferon-α (IFN-α) 10%
• Acute Myeloid Leukemia 10%
• Metabolism 10%
• Bone Marrow 10%
• Induced Differentiation 10%
• Differentiation in Vitro 10%
• Ligand-binding Domain 10%
• Molecular Events 10%
• Remission 10%
• Dimethyl Sulfoxide 10%
• Point mutation 10%
• Terminal Differentiation 10%
• Fusion Protein 10%
• Clinical Observation 10%
• Drug Levels 10%
• Leukemia Cells 10%
• Clinical Remission 10%
• Granulocytes 10%
• Overcoming Resistance 10%
• Vitamin D3 10%
• In Vitro-in Vivo 10%
• Leukemia Patients 10%
• Myeloid Cell Differentiation 10%
• Clinical Approach 10%
• Vitamin A 10%
• Hypoplasia 10%
• Promyelocytic Leukemia 10%
• Hemorrhagic Disease 10%
• In Vivo Observation 10%
• Retinol 10%
• PML-RAR 10%

Medicine and Dentistry

• Tretinoin 100%
• Differentiation Therapy 100%
• Acute Promyelocytic Leukemia 50%
• In Vitro 20%
• Granulocyte 20%
• Retinol 20%
• Malignant Neoplasm 10%
• Cell Differentiation 10%
• Acute Myeloid Leukemia 10%
• Myeloid Cell 10%
• Point Mutation 10%
• Interferon 10%
• Chimeric Protein 10%
• Clinical Observation 10%
• Bioavailability 10%
• Metabolite 10%
• Leukemia Cell 10%
• Vitamin D 10%
• Ligand Binding Domain 10%
• Medical Decision Making 10%
• Dimethyl Sulfoxide 10%
• Phorbol Ester 10%
• Bone Marrow Hypoplasia 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Retinoic Acid 100%
• Promyelocytic Leukemia 50%
• Remission 20%
• Retinol 20%
• Malignant Neoplasm 10%
• Phorbol Ester 10%
• Acute Myeloid Leukemia 10%
• Syndrome 10%
• Interferon 10%
• Chimeric Protein 10%
• Dimethyl Sulfoxide 10%
• Bioavailability 10%
• Cholecalciferol 10%
• Bone Marrow Hypoplasia 10%